| Q47303615 | A Simple Field Procedure for Estimating Ideal Body Weight in Males |
| Q39690075 | Age and the thyroid. |
| Q72622581 | Age-related decrease in repair of oxidative damage to surface sulfhydryl groups on rat adipocytes |
| Q40093544 | Beta-adrenoceptor blocking drugs and the elderly |
| Q37507059 | Body water indices as markers of aging in male masters swimmers |
| Q35113299 | Cardiovascular drug therapy in the elderly: theoretical and practical considerations |
| Q68145303 | Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males |
| Q39774063 | Drug use in the elderly: a review of problems and special considerations |
| Q44123425 | Effect of Aging on Thyroid Economy in Man* |
| Q34409335 | Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). |
| Q35755263 | Effects of resistance training on older adults |
| Q70387854 | Electrolyte disorders in the elderly |
| Q36250800 | Energy Requirements in the Elderly* |
| Q44683318 | Energy dispersive x-ray microanalysis of the electrolytes in biological bulk specimen. II. Age-dependent alterations in the monovalent ion contents of cell nucleus and cytoplasm in rat liver and brain cells |
| Q49162125 | Energy expenditure and fat-free mass in men and women |
| Q40748711 | Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research |
| Q51986096 | Lower resting metabolic rate in the elderly may not be entirely due to changes in body composition. |
| Q37322698 | Manipulation of Ovarian Function Significantly Influenced Sarcopenia in Postreproductive-Age Mice |
| Q74798758 | Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications |
| Q34585115 | Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer |
| Q33770259 | Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly |
| Q51725040 | Pharmacokinetics of sufentanil in the elderly surgical patient. |
| Q34261443 | Pharmacologic management of epilepsy in the elderly. |
| Q35182963 | Pharmacological factors influencing anticancer drug selection in the elderly |
| Q40931106 | Physiological aspects of aging. Implications for the treatment of cancer |
| Q36972965 | Physiological changes due to age. Implications for cardiovascular drug therapy |
| Q71907687 | Quantitative changes of the human cell mass between the 8th and 90th year of life |
| Q36806593 | Review of commonly used age-based weight estimates for paediatric drug dosing in relation to the pharmacokinetic properties of resuscitation drugs |
| Q76558459 | TRENDS IN SELECTED INDICES OF BODY COMPOSITION IN MEN BETWEEN THE AGES 30 AND 80 YEARS |
| Q36972832 | The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)1 |
| Q39689342 | The disposition of cytotoxic drugs in the elderly |
| Q72877065 | The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol |
| Q39761044 | The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly |
| Q30868865 | UNCERTAINTIES IN GERIATRIC DATA. I. FUNCTIONAL OBSERVATIONS |
| Q69017263 | Water and aging |